Acute promyelocytic leukemia Primary Prevention
Acute promyelocytic leukemia Microchapters |
Differentiating Acute promyelocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute promyelocytic leukemia Primary Prevention On the Web |
American Roentgen Ray Society Images of Acute promyelocytic leukemia Primary Prevention |
Directions to Hospitals Treating Acute promyelocytic leukemia |
Risk calculators and risk factors for Acute promyelocytic leukemia Primary Prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no established measures for the primary prevention of acute promyelocytic leukemia
There are no available vaccines against acute promyelocytic leukemia .
Effective measures for the primary prevention of acute promyelocytic leukemia in fatal is
Primary Prevention
- There are no established measures for the primary prevention of acute promyelocytic leukemia .
- There are no available vaccines against acute promyelocytic leukemia .
- White blood cell (WBC) count more than 10,000,000,000
- Advanced age (Age> 60)
- Prevent to exposure benzene
References
- ↑ Grove CS, Vassiliou GS (August 2014). "Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?". Dis Model Mech. 7 (8): 941–51. doi:10.1242/dmm.015974. PMID 25056697.
- ↑ McHale CM, Zhang L, Smith MT (February 2012). "Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment". Carcinogenesis. 33 (2): 240–52. doi:10.1093/carcin/bgr297. PMC 3271273. PMID 22166497.
- ↑ Abedin S, Altman JK (December 2016). "Acute promyelocytic leukemia: preventing early complications and late toxicities". Hematology Am Soc Hematol Educ Program. 2016 (1): 10–15. doi:10.1182/asheducation-2016.1.10. PMC 6142484. PMID 27913456.